Benzinga | Aug 5, 2020 11:02AM EDT

Morgan Stanley Maintains Overweight on Zimmer Biomet Holdings, Raises Price Target to $150

Morgan Stanley maintains Zimmer Biomet Holdings (NYSE:ZBH) with a Overweight and raises the price target from $140 to $150.